openPR Logo
Press release

Global High BP/Hypertension Drugs and Device Market Forecast 2018-2023

01-15-2019 11:37 AM CET | Health & Medicine

Press release from: Orion Market Research

Global High BP/Hypertension Drugs and Device Market

Global High BP/Hypertension Drugs and Device Market

High blood pressure/hypertension drugs and device market size, share, market trends, research and analysis report by drugs (pulmonary, systemic) by monitoring devices (aneroid & mercury sphygmomanometers, digital devices, ambulatory BP monitors) forecast 2018-2023

According to the OMR analysis, the global high BP/hypertension drug and device market is growing at a significant rate during 2018-2023. The global high BP/hypertension drug and device market is showing a significant growth due to increasing incidence of high BP/hypertension. Heart attacks are among the leading cause of death, according to WHO, about 75 million Americans adults have high blood pressure. It is estimated about 54% of American people with high blood pressure are under control. Due to heart disease about 630,000 people in the US die every year. The global high blood pressure/hypertension drug and device market is segmented on the basis of drugs and end-users. The report provides detailed and insightful chapters on market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis and analyst insights.

Full report of global high BP/Hypertension drug and devices market is available at https://www.omrglobal.com/industry-reports/hypertension-drugs-monitoring-device-market/

Furthermore, the technological advancement in hypertension includes mobile-based BP monitoring systems is anticipated to drive the growth of the market. The demand for BP monitors is rising due to growing geriatric population and increasing risk of high blood pressure among population due to rising incidences of obesity & life style related health issues. There are various digital devices in the market which are designed to measure patient’s blood pressure. The pulmonary hypertension can be treated through various type of drugs which includes oral, inhaled, intervenors, medical therapies and on the basis of severity of Ph, heart or lung transplant is also option. The drugs for pulmonary hypertension include ambrisentan, bosentan, iloprost, epoprostenol.

The market on the basis of geography is divided among four major regions – North America, APAC, Europe, and Rest of the world. North America is estimated to have the largest market share during the forecast period 2018-2023. North America dominates the market due to higher level of awareness pertaining to blood pressure monitoring products, increasing demand for hypertension drugs and devices, and growing disease population due to changing lifestyle are contributing to the growth of the market. Asia-Pacific is expected to grow at a rapid pace during the forecast period due to technological advancement in blood pressure monitoring devices, increasing investments by manufacturers, and rising incidences of hypertension.

The report covers:
Comprehensive research methodology of global Hypertension drugs monitoring Device Market.
This report also includes detailed and extensive market overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Hypertension drugs monitoring Device Market.
Insights about market determinants which are stimulating the Hypertension drugs monitoring Device Market.

For related reports please visit https://www.omrglobal.com/reports-category/pharmaceuticals/

For more update follow LinkedIn https://www.linkedin.com/company/omr-global-research/

About Orion Market Research

Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Contact us

Orion Market Research Pvt. Ltd.
Anurag Tiwari
Email: info@omrglobal.com, support@omrglobal.com
India: +91-780-304-0404, +91-917-982-8694
Global:+1-646-755-7667
Indore-India-452010
Web: www.omrglobal.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global High BP/Hypertension Drugs and Device Market Forecast 2018-2023 here

News-ID: 1498526 • Views:

More Releases from Orion Market Research

Antioxidant Beverages Market Update Report 2024| Industry Trends, Demand, Leading Companies and Segmentation till 2031/ Amorepacific Corp., AriZona Beverages USA LLC, Basilur Tea India Pvt. Ltd
Antioxidant Beverages Market Update Report 2024| Industry Trends, Demand, Leadin …
Antioxidant Beverages Market is estimated to grow at a CAGR of nearly 9.0% during the forecast period. The increasing e-commerce market is one of the major factors for augmenting the growth of the market. Introduction of prominent e-commerce companies across the globe such as Alibaba, Amazon, and Walmart are also expected to provide a substantial growth rate to the market. The primary factor that is augmenting the global e-commerce market
US Krill Oil Market Growth Probability, Leading Vendors and Future Scenario By 2024-2031/ Arista Industries Inc.,BASF SE, ConnOils LLC
US Krill Oil Market Growth Probability, Leading Vendors and Future Scenario By 2 …
The US krill oil market is estimated to grow at a CAGR of 10.8% during the forecast period. The major factors that propel the market growth in the country include rising demand of krill in dietary supplements and food & beverages sector due to various health benefits, significant growth in the lifestyle related diseases and others. Growing demand for nutrition in the aging population and rising demand for sports nutrition
UK Krill Oil Market Size, Share, Trends, Demand, Segments, Leading Companies and Forecast till 2031 / Aker Biomarine Antarctic AS, BASF SE, ConnOils LLC
UK Krill Oil Market Size, Share, Trends, Demand, Segments, Leading Companies and …
UK krill oil market is estimated to grow CAGR of 8.9% during the forecast period. The major factors that contributing to the growth of the krill oil market include the rising demand of krill oil in dietary supplements, food & beverages, pharmaceuticals and others, significant awareness regarding the health benefits of krill oil in the country and others. Moreover, high prevalence of chronic diseases, and easy availability of krill oil
North American Krill Oil Market Is Expected to Exhibit Significant Growth Over 2031 / Arista Industries Inc., BASF SE, ConnOils LLC
North American Krill Oil Market Is Expected to Exhibit Significant Growth Over 2 …
The North American krill oil market is estimated to grow at a CAGR of 10.3% during the forecast period. The growth of the market is attributed to the rising demand of dietary supplements coupled growing life style related diseases in the US and Canada. Additionally, increasing demand for functional foods and beverages is also provide ample opportunity to the krill oil market growth in the region. Furthermore, the North American

All 5 Releases


More Releases for Hypertension

Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027. Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC
4th International Conference on Hypertension & Healthcare
We take the privilege of hosting International Hypertension meetings worldwide and very excited to expand to 4th International Conference on Hypertension & Healthcare to be held in beautiful city Zurich, Switzerland in the month of September 10th- 11th, 2018. As with the three meetings, the Hypertension 2018 will be on high-level updates, debates, hot topics and future research directions in the areas of Cardiology, cardiovascular diseases, Pulmonary Hypertension, Hypertension &
Ocular Hypertension - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Ocular Hypertension - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ocular Hypertension - Pipeline Review, H2 2017, provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape. Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous humor
Hypertension: Often unnoticed, always a risk
Vital mushrooms provide a valuable contribution in the prevention and therapy of hypertension Hypertension is considered one of the greatest health problems of the modern age. In the United Kingdom alone, according to data from the NHS, about 12,5 million people - almost every fourth - are affected. The great danger: Although hypertension can cause further serious diseases, many sufferers do not suspect their hypertension. They feel well and have
Ocular Hypertension-Pipeline Review H2 2017
ReportsWeb.com has announced the addition of the “Ocular Hypertension-Pipeline Review H2 2017” this report provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape. Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous humor does not flow through the trabecular meshwork properly, fluid pressure in the eye builds up, causing ocular hypertension. There are no symptoms with ocular hypertension. Risk factors include
Ocular Hypertension - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Ocular Hypertension - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ocular Hypertension - Pipeline Review, H1 2017, provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape. Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous